老年人长期使用苯二氮䓬受体激动剂减药策略的安全性与有效性:系统综述
结果显示减药总体安全,戒断症状多轻微短暂,严重不良事件罕见;结构化逐渐减量停药率或减量率最高,其他策略效果不一。
要点
- 老年人长期使用BZRA减药总体安全,严重不良事件罕见。
- 结构化逐渐减量在停药或减量率上表现最佳。
- 效果因干预类型和情境而异,需个体化减药。
核心结论
- 老年人长期使用BZRA减药可行且总体安全,采用结构化、逐渐及以患者为中心的方法时效果更好。
- 减药有效性因干预类型和情境而异,支持老年医学实践中个体化、循证减药。
研究设计与样本
- 系统综述,遵循PRISMA 2020指南,检索Ovid MEDLINE、PubMed、Embase和PsycINFO从建库至2025年9月。
主要发现
- 干预包括结构化药物逐渐减量、患者导向教育策略、临床医生主导方法和系统层面干预。
- 减药总体安全,戒断症状通常轻微且短暂,严重不良事件罕见。
- 结构化逐渐减量达到最高的停药或减量率,其他方法效果更可变。
临床怎么用
- 老年医学科可采用结构化、逐渐和以患者为中心的减药策略处理长期BZRA使用。
- 根据干预类型和情境个体化选择减药方案,优先考虑结构化逐渐减量。
局限性
- 因研究间异质性大,结果采用叙述性综合而非定量合并。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic use of benzodiazepine receptor agonists (BZRAs) remains common among adults aged 65 years and older, despite long-standing concerns regarding falls, cognitive impairment, functional decline and other adverse outcomes. Multiple strategies to support the deprescribing of BZRAs have been proposed; however, the safety and effectiveness of these deprescribing interventions in older adults have not been comprehensively synthesized across different intervention types. OBJECTIVE: To synthesize the available evidence on the safety and effectiveness of structured strategies to deprescribe chronic BZRA use in adults aged ≥65 years. METHODS: This systematic review was conducted in accordance with PRISMA 2020 guidelines. Ovid MEDLINE, PubMed, Embase and PsycINFO were searched from database inception to September 2025. Randomized and nonrandomized studies evaluating structured BZRA-deprescribing interventions in older adults were included. Risk of bias was assessed using design-appropriate tools, and findings were synthesized narratively due to substantial heterogeneity. RESULTS: Thirty studies involving ~11 000 older adults were included. Interventions encompassed structured pharmacologic tapering, patient-directed educational strategies, clinician-led approaches and system-level interventions. Across strategies, deprescribing was generally safe, with withdrawal symptoms typically mild and transient and serious adverse events rare. Structured gradual tapering achieved the highest rates of discontinuation or dose reduction, while other approaches demonstrated more variable effectiveness. CONCLUSION: Deprescribing chronic BZRA use in older adults is feasible and generally safe when implemented using structured, gradual and patient-centred approaches. Effectiveness varies by intervention type and context, supporting an individualized, evidence-informed approach to deprescribing in geriatric practice. PROTOCOL REGISTRATION: International Prospective Register of Systematic Reviews (PROSPERO): CRD420251186411.
引用
- O'Hara-Veintimilla K, Páez-García S, Ramirez-Triana J, et al. Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review. Age Ageing. 2026. PMID: 42089738. doi:10.1093/ageing/afag112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。